Imagen de Portada

Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Sébastien Benzekry, Mélanie Karlsen, Célestin Bigarré, Abdessamad El Kaoutari, Bruno Gomes, Martin Stern, Ales Neubert, Rene Bruno, François Mercier, Suresh Vatakuti, Peter Curle, Candice Jamois
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mechanistic Learning for Survival Prediction in NSCLC Using Routine Blood Biomarkers and Tumor Kinetics
por: Taieb, Ruben, et al.
Publicado: (2026)

Participants in the FDA's Biomarker Qualification Program
por: Mahnum Shahzad, et al.
Publicado: (2025)

Editorial: Hyperferritinaemia—An Ironclad Biomarker for the Prognostication of MASLD?
por: Mark C. C. Cheah, et al.
Publicado: (2025)

Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
por: Kanghee Park, et al.
Publicado: (2025)

SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment
por: Yanan Xu, et al.
Publicado: (2026)

Hepatitis B In Silico Trials Capture Functional Cure, Indicate Mechanistic Pathways, and Suggest Prognostic Biomarker Signatures
por: Javiera Cortés‐Ríos, et al.
Publicado: (2025)

Editorial: Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab for Hepatocellular Carcinoma—Don't Ignore the Risk Factors! Authors' Reply
por: Jonggi Choi
Publicado: (2025)

Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort
por: Najib Ben Khaled, et al.
Publicado: (2025)

Tocilizumab Dosing for Management of T Cell‐Engaging Bispecific Antibody‐Related CRS in Patients With R/R B‐Cell NHL
por: Candice Jamois, et al.
Publicado: (2025)

Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer
por: Maddalena Centanni, et al.
Publicado: (2025)

Identification and Validation of the Ferroptosis‐Related Gene SLC2A1 as a Novel Prognostic Biomarker for Osimertinib Resistance in LUAD
por: Lixia Zhang, et al.
Publicado: (2026)

Reply to “High Pharmacokinetic Variability and Unrecognized Limitations in First‐Line Osimertinib Plus Chemotherapy for EGFR ‐Mutated NSCLC ”
por: Azar Shahraz, et al.
Publicado: (2025)

Comparative Effectiveness of First‐Line Pembrolizumab vs. Chemotherapy in aNSCLC : A Norwegian Population‐Based Cohort Study
por: Simon Boge Brant, et al.
Publicado: (2025)

Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR ‐Mutated Advanced NSCLC
por: Jincheng Yang, et al.
Publicado: (2025)

Letter: Enhancing gastric cancer prevention—The need for a comprehensive three‐tier emergency management strategy. Authors' reply
por: Irene Ligato, et al.
Publicado: (2024)

Surviving Hepatitis C—Understanding Death and Survival Beyond Cure
por: Paul J. Clark, et al.
Publicado: (2025)

Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
por: Lars Masanneck, et al.
Publicado: (2024)

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
por: Caroline Marra, et al.
Publicado: (2024)

Black Phosphorus Microbubbles Combined with Ultrasound for Treating Parkinson's Disease
por: Shuyuan Guo, et al.
Publicado: (2024)

Characterisation and Prognostic Implication of Cholestasis After Burn Injury
por: Lorenz Semmler, et al.
Publicado: (2026)

The Application Value of Brain Natriuretic Peptide in the Prognostic Evaluation of Patients With Chronic Left Heart Failure
por: Congling Xiang, et al.
Publicado: (2025)

Prognostic value of Glasgow prognostic score in patients undergoing hemodialysis
por: Ryosuke Sakamoto, et al.
Publicado: (2025)

Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease
por: Muhammad Osama, et al.
Publicado: (2024)

Discovery and Validation of Potential Serum Biomarkers for Heart Failure by Untargeted Metabolomics
por: Guisheng Zhou, et al.
Publicado: (2024)

Intra‐Articular Injectable Chitosan‐PVA Hydrogel Ingrained With Gallic Acid Loaded Mesoporous Silica Nanoparticles for Pain Relief and Cartilage Regeneration in Obese Osteoarthritic Rats
por: Syed Nasar Rahaman, et al.
Publicado: (2026)

Impact of Endurance Exercise Training on Biomarkers of Aortic Endothelial Damage in Diabetic Rats
por: Mahtab Fouladi, et al.
Publicado: (2024)

Black Phosphorus Microbubbles Combined with Ultrasound for Treating Parkinson's Disease (Adv. Therap. 5/2024)
por: Shuyuan Guo, et al.
Publicado: (2024)

Metabolic Profiling Reveals Diagnostic Biomarkers for Distinguishing Myocarditis From Acute Myocardial Infarction
por: Yuting Chen, et al.
Publicado: (2025)

MMP2‐Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti‐Cancer Drugs in Treating Melanoma
por: Antonio Renda, et al.
Publicado: (2025)

Efficacy and Safety of Stellate Ganglion Block for Treating Angina Pectoris: A Systematic Review and Meta‐Analysis
por: Ying Wei, et al.
Publicado: (2025)

Biomarkers Related to Peritoneal Transfer Function and Dialysis Adequacy
por: Shuyi Pu, et al.
Publicado: (2025)

Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus
Publicado: (2024)

Editorial: Can dietary gluten restriction improve hepatic steatosis?
por: Hariklia Kranidioti, et al.
Publicado: (2024)

Editorial: Viral hepatitis elimination: Still a big challenge: Care is not only for C
por: Nikolaos Papadopoulos, et al.
Publicado: (2024)

Estrogen‐Related Receptor Gamma (ERRγ) as Biomarker and Novel Target for Therapeutic Intervention on Cancer: A Review
por: Priyanka Upadhyay, et al.
Publicado: (2024)

Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel‐Treated Participants
por: Luis Ortega‐Paz, et al.
Publicado: (2025)

Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases
por: Tomoya Nakamizo, et al.
Publicado: (2026)

Editorial: The Appendix—A Dead End for Treating Ulcerative Colitis, After All?
por: Johan D. Söderholm
Publicado: (2025)

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
por: Ko‐Hsiu Lu, et al.
Publicado: (2026)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
por: Lukas Burghart, et al.
Publicado: (2026)